SEC Form 4 · accession 0001144204-18-065170
MUSTANG BIO, INC. · MBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Manuel Litchman M.D.
Officer — President and CEO · Director
Period of report
Nov 20, 2018
Accepted (ET)
Dec 18, 2018 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001680048
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 20, 2018 | P | 2,500 | $3.8881 | A | 2,500 | D | |
| Common StockF1 | Nov 21, 2018 | P | 5,000 | $4.2096 | A | 7,500 | D | |
| Common StockF1 | Nov 26, 2018 | P | 5,000 | $3.8707 | A | 12,500 | D | |
| Common Stock | Dec 4, 2018 | P | 7,500 | $3.60 | A | 20,000 | D | |
| Common StockF1 | Dec 10, 2018 | P | 8,000 | $3.3506 | A | 28,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 20, 2018 was $3.8751 to $3.8951, the range of prices for the purchase transactions on November 21, 2018 was $4.1992 to $4.219, the range of prices for the purchase transactions on November 26, 2018 was $3.8696 to $3.8708 and the range of prices for the purchase transactions on December 10, 2018 was $ 3.34 to $ 3.3532. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.